Mitral fibroelastic deficiency

Article written and reviewed by Dr Luca Moretti

Mitral fibroelastic deficiency is one of the two classic phenotypes of degenerative valve disease that causes primary mitral regurgitation, alongside Barlow disease. The term does not describe a simple lack of fibers demonstrable by a single test, but a clinical, morphological and surgical pattern: globally thin and nonredundant leaflet tissue, delicate chordae, disease confined to one or a few segments, and frequent chordal rupture with prolapse or a flail leaflet. The posterior P2 segment is the prototypical target, not an obligatory site.

The diagnosis is important because it anticipates the geometry of repair and, in expert hands, a high probability of a durable result. It should not, however, be used as an absolute label. A continuum exists between pure fibroelastic deficiency, diffuse Barlow disease and fibroelastic degeneration with a locally myxomatous segment. Age, disease duration and mechanical load can modify the phenotype; the anatomy actually observed takes precedence over the name.

Fibroelastic deficiency does not coincide with every single-segment prolapse and is not synonymous with acute mitral regurgitation. A patient may maintain compensated regurgitation for a long time after gradual chordal rupture, whereas sudden rupture in a small atrium can cause pulmonary edema. This monograph therefore concerns the tissue disease and its typical mechanism; hemodynamic severity, clinical status and urgency must be established separately.

Definition, pathology and distinction from related phenotypes

Modern etiologic classification of degenerative disease distinguishes phenotypes that the generic term "myxomatous" tended to conflate. In fibroelastic deficiency, nonprolapsing portions are translucent, thin and close to normal in size; the annulus may be only moderately dilated and calcification is less dominant than in complex degenerative disease of older patients. The visible lesion is often disproportionately focal: a marginal chord elongates or ruptures and releases the free edge of a scallop.

The original definition postulated reduced production of collagen, elastin and proteoglycans with thinning of connective tissue. Comparative histology has shown a more complex reality. Excised segments may show matrix disorganization, fibrosa abnormalities, proteoglycan changes and focal thickening, especially in the segment exposed to stress. Apparently normal tissue and the flail segment are not necessarily identical. FED is therefore primarily an anatomoclinical phenotype, not a molecular diagnosis demonstrated by echocardiography.

In Barlow disease, by contrast, the leaflets are broad, thick and redundant, with multisegment prolapse, elongated chordae of variable length, and a dilated, flattened annulus; calcification and annular disjunction may accompany the phenotype. Presentation is often earlier and remodeling reflects a long disease history. In FED, the classic presentation occurs at an older age, with nearly normal uninvolved tissue and a rupture that reveals a previously silent process.

The distinction between fibroelastic deficiency and other degenerative phenotypes has practical, not merely terminological, consequences. An isolated P2 lesion often offers a relatively standardized repair strategy, whereas multisegment Barlow disease requires control of leaflet height, tissue volume, commissures and the risk of systolic anterior motion. At the same time, labeling every simple flail as FED can conceal a broad anterior leaflet, commissural disease or a calcified annulus that reduces repairability: the report should therefore describe anatomy rather than stop at the phenotype label.

Mitral valve prolapse is a description of motion: one or both leaflets cross the annular plane in systole. A flail leaflet is a more specific lesion in which the free edge loses its support and everts into the atrium. FED is a degenerative etiology that often leads to these motion abnormalities, but endocarditis, trauma or papillary muscle rupture can produce a flail leaflet without FED. Etiology, lesion and dysfunction belong to different diagnostic levels.

There is no circulating biomarker or clinical genetic test capable of confirming FED. Familial forms of prolapse, connective tissue syndromes and known genetic variants mainly concern broader spectra of disease. A careful family history remains useful, but the classic phenotype is generally sporadic. Diagnosis arises from convergence of age, morphology, lesion distribution, imaging and operative observation.

Even gross examination of resected tissue must be interpreted cautiously because the surgeon removes the most abnormal segment, and a P2 resection does not represent the whole valve. Fixation, orientation and sampling site also alter apparent matrix thickness and composition. Histologic studies have therefore moderated the idea of two perfectly dichotomous diseases and shown shared remodeling with quantitative differences; clinically, it is more useful to describe a predominantly FED, Barlow or intermediate phenotype.

Chordal rupture, regurgitation and natural history

Marginal chordae prevent the free leaflet edge from everting into the atrium. When their tensile strength falls, repeated systolic loading causes elongation, partial rupture or complete rupture. Loss of one chord may be compensated by adjacent insertions; rupture of multiple primary chordae releases a larger portion of the leaflet and creates a coaptation gap. Ventricular pressure pushes the segment into the atrium and the jet is generally directed away from the affected leaflet.

A posterior flail leaflet tends to generate an anteriorly directed eccentric jet, whereas an anterior flail leaflet more often directs the jet posteriorly. The Coandă effect, however, may cause the jet to hug the atrial wall and make its color Doppler area appear smaller even when regurgitation is severe; commissural lesions, multiple orifices, three-dimensional orientation and loading conditions can also alter the expected direction. Segmental anatomy should therefore be demonstrated in multiple views rather than inferred from jet direction alone.

The hemodynamic consequences depend decisively on how quickly regurgitation develops. If chordal rupture evolves gradually, the atrium and ventricle have time to dilate and accommodate the retrograde volume while initially maintaining relatively low pressures; total stroke volume rises and ejection fraction may remain supranormal even as effective forward output falls. When the atrium has not had time to adapt, the same regurgitant orifice area may produce a large V wave, pulmonary congestion and instability.

Compensatory remodeling is not benign. The ventricle ejects through a low-impedance pathway, so an apparently normal ejection fraction can mask loss of contractility. End-systolic dilation, ejection fraction falling toward decision thresholds, increasing atrial volume, atrial fibrillation and rising pulmonary pressure indicate that the biological cost has increased. The thresholds for severe primary mitral regurgitation apply regardless of the FED label.

Historical cohorts of flail-related regurgitation documented frequent heart failure, atrial fibrillation and need for intervention during follow-up. These data established flail leaflet as a model of important organic regurgitation, but they do not justify assigning the same risk to every contemporary patient: the registries included eras with imaging, therapy and surgical outcomes different from those of today. Mechanism, regurgitation severity, age and comorbidity determine individual prognosis.

Typical symptoms are exertional dyspnea, reduced exercise capacity, fatigue and palpitations. Behavioral adaptation may precede reported dyspnea; exercise testing clarifies discrepancies between history and apparent severity. A holosystolic apical murmur radiating to the axilla is common, but a very eccentric jet may radiate to the base or back. In acute rupture, the murmur may be short because atrial and ventricular pressures equalize early.

Endocarditis, papillary muscle ischemia, chest trauma and inflammatory diseases should be excluded when presentation is sudden or atypical. Fever, positive blood cultures, vegetations or perforation point toward infection; infarction with instability and a mobile papillary mass suggests muscle rupture, a different and much more urgent condition. FED may coexist with coronary artery disease but does not automatically explain every rupture.

Rupture can also propagate mechanical damage. A free segment increases tension on adjacent chordae and changes force distribution; an initially narrow flail segment may therefore widen. The rate is unpredictable and does not justify intervention solely because of a mild chordal rupture, but it explains why a change in murmur or symptoms requires repeat echocardiography without waiting for the scheduled visit.

Echocardiographic diagnosis and quantification

Transthoracic echocardiography is the initial examination. Parasternal long-axis and apical views show systolic displacement beyond the annular plane, eversion of the free edge and, at times, the linear echo of a ruptured chord. Short-axis views localize the scallops; assessment should include the thickness of remaining tissue, posterior leaflet height, annular dimensions, calcification, ventricular function and right-sided chambers.

A rigorous diagnosis states which leaflet and segment are involved, whether the motion is prolapse or flail, whether the lesion is isolated or multisegment, the size of the gap and flail width, and whether clefts, commissural abnormalities or secondary chordae are present. Three-dimensional transesophageal echocardiography provides an en face view similar to the surgical view and clarifies P1-P2-P3, A1-A2-A3 and commissural regions.

The FED phenotype is supported by thin uninvolved leaflets, absence of diffuse redundancy and a circumscribed lesion. A flail segment may appear locally thickened because of remodeling; this does not automatically convert the phenotype into Barlow disease. Conversely, a broad billowing surface, several prolapsing scallops and diffusely elongated chordae make pure FED inappropriate. The morphological differential diagnosis should be reported as a degree of probability when images are not definitive.

Regurgitation severity requires multiparametric integration. Vena contracta, effective regurgitant orifice area, regurgitant volume and fraction, density and contour of the continuous-wave Doppler signal, pulmonary venous flow, mitral E waves and chamber remodeling should be interpreted together. In eccentric jets, color Doppler jet area is particularly unreliable; PISA can be distorted by the wall and by a noncircular orifice.

Quantification must also account for the systolic timing of regurgitation. A flail leaflet often produces a holosystolic jet, but some degenerative lesions are mid- to late-systolic, and applying an instantaneous PISA radius to the whole systole can overestimate volume; blood pressure, heart rate, volume status and sedation further modify severity. When direct signs and chamber dimensions are discordant, the correct response is to reassess technique and examination conditions rather than arithmetically average discordant grades.

Cardiac magnetic resonance imaging is useful when echocardiography does not convincingly quantify regurgitation or ventricular volumes. It calculates regurgitant volume mainly as the difference between left ventricular stroke volume and aortic flow, assesses function and fibrosis, and does not depend on jet shape. Arrhythmias, shunts and other valvular regurgitation can alter indirect methods and should be recognized.

Exercise echocardiography assesses objective capacity, the rise in pulmonary pressure and dynamic behavior in patients with discordant symptoms. ECG monitoring is indicated for palpitations, syncope or ectopy, but focal FED does not automatically carry the arrhythmic profile described in bileaflet prolapse with annular disjunction. Magnetic resonance imaging and Holter monitoring should answer a clinical suspicion, not replace staging of regurgitation.

The preoperative report should become a repairability map: lesion, quality of reference segments, leaflet height and length, annulus, calcium, leaflet-to-septum relationship, ventricular dimensions and predictors of systolic anterior motion. Isolated posterior FED often has favorable anatomy; anterior or commissural disease, calcification or multisegment involvement increases complexity without making replacement inevitable.

Cardiopulmonary exercise testing can measure oxygen consumption, ventilatory efficiency and blood pressure response in patients who report good capacity despite important regurgitation. It provides no FED-specific threshold, but separates deconditioning from circulatory limitation and creates an objective reference. The test should be integrated with imaging and not performed when acute presentation or instability makes it inappropriate.

Repair, indications and alternatives

Medical therapy relieves congestion and treats hypertension, atrial fibrillation and other conditions but does not recreate chordal support. In patients with severe regurgitation, the goal is to correct the lesion before irreversible ventricular dysfunction develops. Contemporary indications integrate symptoms, ejection fraction and end-systolic diameter, atrial fibrillation, pulmonary pressure, operative risk and the likelihood of durable repair at a Heart Valve Centre.

Surgical repair is preferred to replacement when a stable result is expected. In a focal posterior lesion, PTFE neochordae, limited triangular or quadrangular resection, folding or sliding techniques and closure of selected clefts can be used. Complete annuloplasty stabilizes annular size and distributes forces. The choice is not ideological: it should preserve mobility, achieve a broad coaptation surface and avoid stenosis.

Neochordae restore support without removing tissue, and their length is calibrated against normal segments and ventricular geometry; resection, by contrast, removes the flail portion but, if excessive, reduces available leaflet area and can alter the annulus. In FED, where tissue is often limited, conservative strategies are therefore particularly useful. Intraoperative assessment should confirm minimal residual regurgitation, an acceptable gradient, adequate coaptation length and absence of systolic anterior motion under representative loading conditions.

The risk of SAM is generally lower than in tissue-rich Barlow disease but is not zero. A tall posterior leaflet, an undersized ring, a narrow mitral-aortic angle and a small hyperdynamic ventricle shift coaptation anteriorly. Prevention depends on geometric analysis, correct ring sizing and control of posterior leaflet height; intraoperative treatment corrects volume status, inotropic support and, if necessary, the repair itself.

Replacement becomes appropriate when destructive infection, severe calcification, insufficient tissue or anatomical complexity prevents a reliable repair. The subvalvular apparatus is preserved whenever possible, while the choice between a bioprosthesis and mechanical prosthesis depends on age, life expectancy, anticoagulation, pregnancy, reintervention risk and future valve-in-valve options. In this setting, replacement is not a failure of a repair strategy but may be the safest and most durable solution.

Transcatheter edge-to-edge repair can reduce regurgitation in symptomatic patients with severe primary regurgitation, high surgical risk and suitable anatomy. A focal flail lesion may be treatable if gap, width, valve area, calcium and tissue quality in the grasping zone are favorable. The procedure does not reconstruct the chord and may leave residual regurgitation or a gradient; in a low-risk candidate for surgical repair it is not automatically an equivalent alternative in terms of durability.

Transapical beating-heart neochordal implantation techniques and transcatheter replacement systems are selected or evolving options. The relatively simple anatomy of FED does not eliminate the need for comparative evidence and long follow-up. An innovative treatment should be judged by survival, symptoms, residual regurgitation, reintervention and preservation of future options, not only by immediate technical success.

Durability of repair depends as much on the quality of residual tissue as on the technique used. Early regurgitation more often suggests an unrecognized lesion, inappropriate chordal length or insufficient annuloplasty, whereas late recurrence may reflect degenerative progression, new rupture or dehiscence. Distinguishing these mechanisms guides reintervention and also allows the quality of the surgical program to be assessed: a high repair rate is meaningful only when accompanied by low residual regurgitation and good long-term freedom from reintervention.

Follow-up, prognosis and individualized decision-making

Follow-up of FED with nonsevere regurgitation monitors symptoms, auscultation, rhythm, ventricular diameters and volumes, ejection fraction, left atrial size, pulmonary pressure and progression of the jet. Frequency is proportional to severity and is brought forward if dyspnea, reduced exercise capacity, palpitations or another clinical change develops. Chordal rupture can rapidly alter a previously stable situation.

In apparently asymptomatic patients with severe regurgitation, exercise testing and serial comparison of reproducible measurements reduce the risk of waiting until occult damage has occurred. A fall in ejection fraction toward 60% in primary regurgitation is not reassuringly normal because part of the stroke volume is ejected into the low-pressure atrium. Likewise, an increasing end-systolic diameter signals deterioration even if day-to-day function appears preserved.

After repair, a baseline echocardiogram is obtained. Residual regurgitation, gradient, leaflet motion, ventricular function and pulmonary pressure are documented; subsequent follow-up looks for recurrence due to elongation or rupture of other chordae, ring dehiscence, degenerative progression or endocarditis. An excellent repair does not end surveillance but changes its objectives.

Prognosis after a durable focal repair is generally favorable, especially before ventricular dysfunction, pulmonary hypertension and persistent atrial fibrillation develop. The older age typical of FED, however, brings frailty, coronary artery disease, kidney disease and other valve disease that may dominate the outcome. Expected benefit should be expressed in years and quality of life, not only operative mortality.

Antibiotic prophylaxis for endocarditis is not indicated for native FED alone; it becomes relevant in high-risk categories specified by guidelines, including some conditions involving prosthetic material. Oral hygiene, treatment of infections, blood pressure control and appropriately adapted physical activity are part of care. No drug or supplement has been shown to rebuild valvular collagen and elastin or selectively prevent chordal rupture.

Diagnostic communication should avoid two extremes. Calling FED a "mild" form because it is focal underestimates the possibility of severe regurgitation; presenting it as inevitably urgent confuses morphology with hemodynamics. The correct decision follows a sequence: confirm the phenotype, localize the lesion, quantify regurgitation, measure its consequences, estimate repairability and choose the time at which the net benefit of intervention is greatest.